Daily Ards Research Analysis
Three papers advance ARDS science across prognostication, causality, and mechanism. A cohort study shows that combining elastic power and functional residual capacity improves mortality prediction and may guide ventilation. A Mendelian randomization analysis implicates CKD as a causal risk factor for ARDS via inflammatory and PTH-mediated pathways, while a mouse study identifies pendrin inhibition and prone positioning as synergistic strategies to mitigate ventilator-induced lung injury.
Summary
Three papers advance ARDS science across prognostication, causality, and mechanism. A cohort study shows that combining elastic power and functional residual capacity improves mortality prediction and may guide ventilation. A Mendelian randomization analysis implicates CKD as a causal risk factor for ARDS via inflammatory and PTH-mediated pathways, while a mouse study identifies pendrin inhibition and prone positioning as synergistic strategies to mitigate ventilator-induced lung injury.
Research Themes
- Ventilation biomechanics and prognostication in ARDS
- Renal–pulmonary axis and causal risk for ARDS
- Ion transporters and positional therapy in VILI/ARDS
Selected Articles
1. The mechanisms of kidney-lung interactions in chronic kidney disease-associated pulmonary diseases: A two-sample Mendelian randomization study.
Using two-sample Mendelian randomization, genetically predicted CKD was causally associated with increased risk of ARDS (OR 2.11) and other pulmonary diseases. Mediation analyses implicated IL-1β, TNF, and PTH/25(OH)D pathways in kidney–lung interactions, suggesting actionable biological targets.
Impact: Establishes a causal link between CKD and ARDS and identifies mechanistic mediators, reframing ARDS risk assessment in nephrology populations.
Clinical Implications: CKD patients may benefit from enhanced respiratory risk stratification and preventive strategies. Targeting PTH/vitamin D axis and systemic inflammation (IL-1β, TNF) could be explored to reduce ARDS risk.
Key Findings
- Genetically predicted CKD increased ARDS risk (OR 2.110, 95% CI 1.053–4.231).
- CKD was causally associated with higher risks of pneumonia (OR 1.066) and small but significant increases in asthma and COPD risk.
- Mediation analysis identified IL-1β (pneumonia), TNF (asthma and COPD), and PTH (pneumonia and ARDS) as partial mediators (3.53%–27.15%).
Methodological Strengths
- Two-sample MR with IVW as primary estimator plus complementary methods (weighted median, ML, MR-RAPS).
- Two-step MR mediation to dissect biological pathways (IL-1β, TNF, PTH/25[OH]D).
Limitations
- Potential pleiotropy and weak instrument bias cannot be fully excluded.
- Ancestry and phenotype heterogeneity of source GWAS may limit generalizability; clinical validation is lacking.
Future Directions: Validate findings in diverse ancestries and prospective CKD cohorts; test whether modulating PTH/vitamin D or inflammatory pathways reduces ARDS incidence.
BACKGROUND: The aim of this study was to investigate the relationship between chronic kidney disease and pulmonary diseases, and explore the mechanisms of kidney-lung interactions. METHODS: Two-sample Mendelian randomization (MR) was performed to explore the causal effect of chronic kidney disease (CKD) on pulmonary diseases, and two-step MR was performed to explore the mechanisms of lung-kidney interactions in chronic kidney disease-associated pulmonary diseases. The inverse variance weighted (IVW) meta-analysis was used as the main method for obtaining the MR estimate, and complementary analysis were performed using the weighted median method, maximum-likelihood, MR-RAPS. RESULTS: IVW analysis showed that genetically predicted CKD was positively associated with the increased risks of asthma (OR:1.005, 95%CI:1.001, 1.009), pneumonia (OR:1.066, 95%CI: 1.009, 1.127), adult respiratory distress syndrome (ARDS) (OR:2.110, 95%CI: 1.053, 4.231), and chronic obstructive pulmonary disease (COPD) (OR, 1.004; 95%CI:1.000, 1.008). Mediation analysis revealed that interleukin-1β mediated CKD's effect on pneumonia risk, tumor necrosis-α mediated its effects on both asthma and COPD, and parathyroid hormone (PTH) mediated its effects on pneumonia and ARDS, with mediated effects size ranging from 3.53% to 27.15%. CONCLUSIONS: Predicted CKD was positively associated with the increased risk of asthma, pneumonia, ARDS, and COPD. Furthermore, interleukin-1β and tumor necrosis-α, 25-hydroxyvitamin D and PTH mediated the kidney-lung interactions in CKD-associated pulmonary diseases.
2. Functional residual capacity and elastic power as prognostic markers in acute respiratory distress syndrome.
In 353 ARDS patients with external validation, low FRC and high elastic power independently predicted 28-day mortality. A combined FRC+EP model achieved AUC ~0.81, and an EP cutoff of 21.535 J/min provided high specificity, supporting ventilator strategies that minimize elastic power and optimize lung volume.
Impact: Links bedside-measurable mechanics (FRC, elastic power) to outcomes with external validation, offering actionable prognostic tools for ventilator tailoring.
Clinical Implications: Consider monitoring EP and FRC to guide ventilation: reduce EP by optimizing VT, RR, and PEEP, and use FRC to titrate PEEP to avoid atelectrauma/overdistension. EP >21.5 J/min may flag high-risk patients for intensified monitoring.
Key Findings
- Low FRC and high EP were significantly associated with poor 28-day outcomes (both P<0.001).
- Independent predictors: EP (OR 1.251), FRC (OR 0.956), ARDS severity (OR 8.421), and PEEP (OR 1.338).
- Combined FRC+EP model AUC 0.809 (internal) and 0.819 (external validation).
- EP cutoff 21.535 J/min achieved specificity 0.944.
Methodological Strengths
- External validation cohort with ROC analysis demonstrating reproducibility.
- Multivariable regression adjusting for severity and ventilator parameters; standardized FRC measurement (nitrogen washout).
Limitations
- Retrospective single-center design with potential residual confounding and selection bias.
- FRC measurement feasibility and variability may limit widespread implementation; ventilator settings not randomized.
Future Directions: Prospective multicenter validation and trials testing EP/FRC-guided ventilation protocols to improve outcomes.
OBJECTIVES: To determine if functional residual capacity (FRC) and elastic power (EP) could predict outcomes in patients with acute respiratory distress syndrome (ARDS). METHODS: This retrospective study included 353 ARDS patients admitted to our hospital between 2018 and 2025. Patients were categorized into good (n=251) and poor (n=102) prognosis groups based on their 28-day outcomes. FRC was measured using nitrogen washout, and EP was calculated using the formula: 0.098 × VT × RR × ½(PEEP + Pplat). After comparing these parameters between groups, multivariate regression and ROC analyses were performed to identify predictors. We validated our findings in an external cohort of 101 patients. RESULTS: Poor outcome patients had significantly lower FRC and higher EP (both P<0.001). A positive correlation between EP and mortality was observed (rho=0.298, P<0.001), while FRC showed a significant inverse relationship (rho=-0.177, P<0.001). Multivariate analysis confirmed that EP (OR=1.251, P<0.001), FRC (OR=0.956, P=0.039), ARDS severity (OR=8.421, P<0.001), and PEEP (OR=1.338, P=0.011) were independent predictors of outcomes. A predictive model combining FRC and EP showed strong performance, with an AUC of 0.809 in internal validation and 0.819 in the external cohort. EP alone exhibited a high specificity of 0.944 at a cutoff value of 21.535 J/min. CONCLUSIONS: ARDS patients with low FRC and high EP face an increased risk of mortality. Combining these measures enhances prognostic accuracy and can help tailor ventilation strategies for improved outcomes.
3. Pendrin inhibition is associated with protective effect of prone positioning in a ventilator-induced lung injury mouse model.
In a VILI mouse model, both genetic deletion and pharmacologic inhibition of pendrin reduced lung injury and inflammatory cytokines, while prone positioning independently attenuated inflammation and pendrin expression. Findings identify pendrin as a mechanistic node linking ventilation strategy and epithelial ion transport.
Impact: Reveals pendrin as a modifiable target in ventilator-induced injury and mechanistically connects the protective effect of prone positioning to ion transport.
Clinical Implications: While preclinical, results support exploring pendrin inhibitors and optimizing prone positioning to mitigate ventilator-associated injury in ARDS management.
Key Findings
- Pendrin knockout and pharmacologic inhibition (YS-01) significantly attenuated VILI severity versus wild-type under high tidal volume ventilation.
- Prone positioning reduced lung inflammation and decreased pendrin expression compared with supine ventilation.
- Pendrin downregulation confirmed by Western blot and TEM-immunogold labeling; injury reduction corroborated by BALF cytokines and histopathology.
Methodological Strengths
- Convergent genetic (knockout) and pharmacologic (YS-01) perturbations strengthen causal inference.
- Multi-modal readouts (BALF cytokines, histology, Western blot, TEM-immunogold) enhance mechanistic validity.
Limitations
- Mouse high tidal volume model (30 mL/kg, 5 h) may not fully reflect clinical ARDS ventilation patterns.
- No survival or long-term functional outcomes; translational relevance of YS-01 dosing and safety unknown.
Future Directions: Test pendrin-targeted strategies in infectious and heterogeneous ARDS models; develop clinically viable pendrin inhibitors and identify biomarkers of pendrin activity.
Pendrin (SLC26A4), a transmembrane anion exchanger, is upregulated in inflammatory airway diseases. In this study, we analyzed the role of pendrin expression in a ventilator-induced acute lung injury (VILI) animal model. VILI was induced in the supine or prone position by a high tidal volume (HTV) of 30 mL/kg for 5 h in pendrin wild-type (WT) and knockout (KO) 129SVEV mice. Pendrin inhibitor (YS-01) was intraperitoneally administered to modulate pendrin signaling. Lung injury parameters were assessed based on bronchoalveolar lavage fluid (BALF) analysis, inflammatory cytokine analysis by ELISA, and histopathological findings. Pendrin expression was determined by western blotting and transmission electron microscopy (TEM) using immunogold labeling methods. The degree of lung injury was significantly attenuated in pendrin-KO mice and pendrin-WT mice with YS-01 compared with pendrin-WT animals after HTV ventilation. Pendrin expression was down-regulated in pendrin-KO mice and pendrin-WT mice with YS-01 compared with pendrin-WT mice with VILI, as determined by western blotting and TEM-immunogold labeling. Prone positioning during ventilation attenuated lung inflammation and pendrin expression. Our results suggest that pendrin is critical in VILI and could be a novel target for modulating VILI. Prone positioning and pendrin inhibition in VILI may be effective in managing these conditions.